What We Do
Eyevance is focused on developing innovative and impactful therapies that address the unmet needs of patients and their ophthalmic healthcare providers.

- Post Op Inflammation
- Dry Eye
- Blepharitis
- Conjunctivitis (Allergic, Viral, Bacterial)
- Retina – AMD, DME, RVO
- Uveitis, Sustained Drug Delivery
- Sustained Drug Delivery
- IOP Lowering therapies
- First of its kind
- Unmet medical need with no present therapeutic option
- Unique biologic/small molecule profile
Target
Anterior Segment
- Post Op Inflammation
- Dry Eye
- Blepharitis
- Conjunctivitis (Allergic, Viral, Bacterial)
Posterior Segment
- Retina – AMD, DME, RVO
- Uveitis, Sustained Drug Delivery
Glaucoma
- Sustained Drug Delivery
- IOP Lowering therapies
Rare/Orphan
- First of its kind
- Unmet medical need with no FDA-approved
therapeutic alternatives - Unique biologic/small molecule profile
Our Mission
Eyevance Pharmaceuticals’ mission is to develop and commercialize innovative and impactful ophthalmic products to enable optimal vision and better quality of life for all patients.
Connect With Eyevance